Charts & intelligence
Fundamentals
Financials
Activity
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Ventripoint Diagnostics' VMS+ Technology Selected for World-First AI Cardiac Monitoring Study in Breast Cancer Patients
Eli Lilly seeks higher NHS drug prices, rebate overhaul to restart UK investment, FT reports